Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Association between Participation in Government Subsidy Program for Domestic Travel and Symptoms Indicative of COVID-19 Infection

View ORCID ProfileAtsushi Miyawaki, Takahiro Tabuchi, Yasutake Tomata, View ORCID ProfileYusuke Tsugawa
doi: https://doi.org/10.1101/2020.12.03.20243352
Atsushi Miyawaki
1Department of Public Health, Graduate School of Medicine, the University of Tokyo, Bunkyo-Ku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Atsushi Miyawaki
Takahiro Tabuchi
2Cancer Control Center, Osaka International Cancer Institute, Osaka, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasutake Tomata
3Faculty of Health and Social Services, Kanagawa University of Human Services, Yokosuka, Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yusuke Tsugawa
4Division of General Internal Medicine and Health Services Research, UCLA David Geffen School of Medicine, Los Angeles, CA
5Department of Health Policy and Management, UCLA Fielding School of Public Health, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yusuke Tsugawa
  • For correspondence: ytsugawa@mednet.ucla.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Importance As countermeasures against the economic downturn caused by the coronavirus 2019 (COVID-19) pandemic, many countries have introduced or considering financial incentives for people to engage in economic activities such as travel and use restaurants. Japan has implemented a large-scale, nationwide government-funded program that subsidizes up to 50% of all travel expenses since July 2020 with the aim of reviving the travel industry. However, it remains unknown as to how such provision of government subsidies for travel impacted the COVID-19 pandemic.

Objective To investigate the association between participation in government subsidies for domestic travel in Japan and the incidence of COVID-19 infections.

Design, Setting, and Participants Using the data from a large internet survey conducted between August 25 and September 30, 2020, in Japan, we examined whether individuals who used subsidies experienced a higher likelihood of symptoms indicative of the COVID-19 infection.

Exposure Participation in the government subsidy program for domestic travel.

Main Outcomes and Measures Five symptoms indicative of the COVID-19 infection (high fever, sore throat, cough, headache, and smell and taste disorder) within the past one month of the survey.

Results Of the 25,482 respondents (50.3% [12,809] women; mean [SD] age, 48.4 [17.4] years), 3,289 (12.9%) participated in the subsidy program at the time of survey. After adjusting for potential confounders, we found that participants in the subsidy program exhibited higher incidence of high fever (adjusted rate, 4.8% for participants vs. 3.7% for non-participants; adjusted odds ratio [aOR], 1.90; 95%CI, 1.42-2.54; p<0.001), sore throat (19.8% vs. 11.3%; aOR, 2.09; 95%CI, 1.37-3.20; p=0.002), cough (19.1% vs. 11.2%; aOR 1.96; 95%CI, 1.27-3.02; p=0.007), headache (29.1% vs. 25.5%; aOR, 1.24; 95%CI, 1.07-1.43; p=0.007), and smell and taste disorder (2.6% vs. 1.8%; aOR 1.98; 95%CI; 1.15-3.40; p=0.01) compared with non-participants.

Conclusion and Relevance The participants of government subsidies for domestic travel experienced a higher incidence of symptoms indicative of the COVID-19 infection.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grants [grant number 17H03589;19K10671;19K10446;18H03107; 18H03062], the JSPS Grant-in-Aid for Young Scientists [grant number 19K19439], Research Support Program to Apply the Wisdom of the University to tackle COVID-19 Related Emergency Problems, University of Tsukuba, and Health Labour Sciences Research Grant [grant number 19FA1005;19FG2001]. Dr. Miyawaki was supported by the JSPS KAKENHI Grants [grant number 20K18956] and the Social Science Research Council Abe Fellowship. Dr. Tsugawa was supported by the National Institute of Health (NIH)/NIMHD Grant R01MD013913 and NIH/NIA Grant R01AG068633.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Institutional Review Board of the Osaka International Cancer Institute (No. 20084).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • The categorization of employment status (adjustment variable) was updated (employer, self-employed, employee, and unemployed)

Data Availability

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 19, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Association between Participation in Government Subsidy Program for Domestic Travel and Symptoms Indicative of COVID-19 Infection
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Association between Participation in Government Subsidy Program for Domestic Travel and Symptoms Indicative of COVID-19 Infection
Atsushi Miyawaki, Takahiro Tabuchi, Yasutake Tomata, Yusuke Tsugawa
medRxiv 2020.12.03.20243352; doi: https://doi.org/10.1101/2020.12.03.20243352
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Association between Participation in Government Subsidy Program for Domestic Travel and Symptoms Indicative of COVID-19 Infection
Atsushi Miyawaki, Takahiro Tabuchi, Yasutake Tomata, Yusuke Tsugawa
medRxiv 2020.12.03.20243352; doi: https://doi.org/10.1101/2020.12.03.20243352

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (500)
  • Anesthesia (110)
  • Cardiovascular Medicine (1230)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (529)
  • Epidemiology (10008)
  • Forensic Medicine (5)
  • Gastroenterology (497)
  • Genetic and Genomic Medicine (2445)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1635)
  • Health Policy (751)
  • Health Systems and Quality Improvement (633)
  • Hematology (248)
  • HIV/AIDS (531)
  • Infectious Diseases (except HIV/AIDS) (11856)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (251)
  • Medical Ethics (74)
  • Nephrology (268)
  • Neurology (2275)
  • Nursing (139)
  • Nutrition (350)
  • Obstetrics and Gynecology (452)
  • Occupational and Environmental Health (532)
  • Oncology (1244)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (154)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (729)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4825)
  • Radiology and Imaging (833)
  • Rehabilitation Medicine and Physical Therapy (488)
  • Respiratory Medicine (650)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (225)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (124)
  • Urology (99)